loading
Cero Therapeutics Holdings Inc stock is traded at $3.3401, with a volume of 128.45K. It is up +2.24% in the last 24 hours and down -37.33% over the past month. CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
See More
Previous Close:
$3.31
Open:
$3.45
24h Volume:
128.45K
Relative Volume:
0.75
Market Cap:
$4.03M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-37.22%
1M Performance:
-37.33%
6M Performance:
-98.79%
1Y Performance:
-99.91%
1-Day Range:
Value
$3.34
$3.69
1-Week Range:
Value
$3.15
$5.6588
52-Week Range:
Value
$3.15
$17,908.00

Cero Therapeutics Holdings Inc Stock (CERO) Company Profile

Name
Name
Cero Therapeutics Holdings Inc
Name
Phone
650-407-2376
Name
Address
201 HASKINS WAY, SOUTH SAN FRANCISCO
Name
Employee
8
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
CERO's Discussions on Twitter

Compare CERO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CERO
Cero Therapeutics Holdings Inc
3.34 3.99M 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.85 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
460.67 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
550.62 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
801.98 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.25 35.16B 4.56B -176.77M 225.30M -1.7177

Cero Therapeutics Holdings Inc Stock (CERO) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-23-25 Upgrade D. Boral Capital Hold → Buy

Cero Therapeutics Holdings Inc Stock (CERO) Latest News

pulisher
12:47 PM

Can CERo Therapeutics Holdings Inc. Equity Warrant hit a new high this monthWatch List & Accurate Technical Buy Alerts - newser.com

12:47 PM
pulisher
12:39 PM

Using data tools to time your CERo Therapeutics Holdings Inc. exitMarket Growth Report & Community Consensus Picks - newser.com

12:39 PM
pulisher
Oct 12, 2025

Is CERo Therapeutics Holdings Inc. Equity Warrant stock attractive for hedge funds2025 Price Targets & Precise Trade Entry Recommendations - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Why CERo Therapeutics Holdings Inc. stock is seen as undervaluedBreakout Watch & Verified Momentum Stock Alerts - newser.com

Oct 12, 2025
pulisher
Oct 12, 2025

Will CERo Therapeutics Holdings Inc. see short term momentumShare Buyback & Low Drawdown Momentum Ideas - newser.com

Oct 12, 2025
pulisher
Oct 10, 2025

What does recent volatility data suggest for CERo Therapeutics Holdings Inc. Equity WarrantJuly 2025 Fed Impact & Low Drawdown Investment Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What MACD signals say about CERo Therapeutics Holdings Inc.2025 Short Interest & Fast Gaining Stock Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How sustainable is CERo Therapeutics Holdings Inc. stock dividend payoutJuly 2025 Update & High Accuracy Trade Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Price momentum metrics for CERo Therapeutics Holdings Inc. Equity Warrant explainedJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Ranking CERo Therapeutics Holdings Inc. among high performing stocks via toolsCEO Change & Daily Stock Trend Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will CERo Therapeutics Holdings Inc. Equity Warrant stock go up soonJuly 2025 PostEarnings & Safe Entry Trade Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Published on: 2025-10-10 02:27:43 - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Analyzing recovery setups for CERo Therapeutics Holdings Inc. Equity Warrant investorsJuly 2025 Setups & Low Risk Profit Maximizing Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How high can CERo Therapeutics Holdings Inc. stock go2025 Bull vs Bear & Risk Controlled Stock Pick Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Is CERo Therapeutics Holdings Inc. Equity Warrant stock a buy in volatile marketsJuly 2025 Short Interest & Weekly Breakout Opportunity Watchlist - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Smart tools for monitoring CERo Therapeutics Holdings Inc.’s price actionDay Trade & Smart Allocation Stock Reports - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Will CERo Therapeutics Holdings Inc. continue its uptrendOptions Play & Community Driven Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Is CERo Therapeutics Holdings Inc. Equity Warrant stock oversold or undervaluedInsider Buying & Daily Entry Point Trade Alerts - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

Understanding CERo Therapeutics Holdings Inc.’s price movement2025 Volatility Report & Free Expert Verified Stock Movement Alerts - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

How to interpret RSI for CERo Therapeutics Holdings Inc. Equity Warrant stock2025 Performance Recap & Technical Pattern Alert System - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

What’s the recovery path for long term holders of CERo Therapeutics Holdings Inc. Equity WarrantWeekly Market Summary & Daily Growth Stock Tips - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Published on: 2025-10-06 04:37:06 - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Why CERo Therapeutics Holdings Inc. Equity Warrant is moving todayJuly 2025 Gainers & Free Reliable Trade Execution Plans - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Technical analysis overview for CERo Therapeutics Holdings Inc. Equity Warrant stockQuarterly Profit Summary & Real-Time Stock Movement Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

How CERo Therapeutics Holdings Inc. Equity Warrant stock compares to growth peersWeekly Gains Summary & Technical Entry and Exit Tips - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

What high frequency data says about CERo Therapeutics Holdings Inc.2025 Trading Volume Trends & High Accuracy Swing Trade Signals - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

Can you recover from losses in CERo Therapeutics Holdings Inc.2025 Biggest Moves & Short-Term Trading Opportunity Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Published on: 2025-10-02 18:50:27 - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Candlestick signals on CERo Therapeutics Holdings Inc. Equity Warrant stock todayBond Market & Daily Growth Stock Tips - newser.com

Oct 02, 2025
pulisher
Oct 02, 2025

Published on: 2025-10-02 21:58:05 - newser.com

Oct 02, 2025
pulisher
Oct 01, 2025

Is CERo Therapeutics Holdings Inc a good long term investmentDividend Growth Stocks & Affordable Growth Strategies - earlytimes.in

Oct 01, 2025
pulisher
Sep 29, 2025

CERo Therapeutics announces up to $8M Series D financing; shares up - MSN

Sep 29, 2025
pulisher
Sep 29, 2025

Published on: 2025-09-29 10:29:39 - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

Published on: 2025-09-29 10:03:58 - newser.com

Sep 29, 2025

Cero Therapeutics Holdings Inc Stock (CERO) Financials Data

There is no financial data for Cero Therapeutics Holdings Inc (CERO). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Cero Therapeutics Holdings Inc Stock (CERO) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
YK Bioventures Opportunities G
10% Owner
Dec 13 '24
Sale
0.06
2,998,908
179,934
13,005,169
YK Bioventures Opportunities G
10% Owner
Dec 12 '24
Sale
0.07
1,614,541
113,018
16,004,077
YK Bioventures Opportunities G
10% Owner
Dec 11 '24
Sale
0.08
1,343,801
107,504
17,618,618
YK Bioventures Opportunities G
10% Owner
Dec 06 '24
Sale
0.12
1,236,874
148,425
21,383,909
YK Bioventures Opportunities G
10% Owner
Dec 10 '24
Sale
0.09
1,570,947
141,385
18,962,419
YK Bioventures Opportunities G
10% Owner
Dec 09 '24
Sale
0.11
850,543
93,560
20,533,366
$21.92
price up icon 3.07%
$83.54
price down icon 0.21%
$32.12
price up icon 1.01%
$102.47
price up icon 0.39%
$163.93
price up icon 0.51%
biotechnology ONC
$327.15
price up icon 2.24%
Cap:     |  Volume (24h):